Table 1.
Clinical characteristics of Kpn infected patients (n = 501).
| Variables | Resistant to one/two antibiotic | Multidrug-resistant | Total cases (n = 501) | Pearson's c2 | P-value |
|---|---|---|---|---|---|
| Gender | |||||
| Male | 36 (14.87%) | 189 (78.099%) | 242 (48.303%) | 104.04 | <0.001 |
| Female | 75 (28.95%) | 167 (64.478%) | 259 (51.696%) | 34.975 | |
|
| |||||
| Age Groups | |||||
| Baby/Newborn (0–4 weeks) | 45 (20.93%) | 143 (66.51%) | 215 (42.91%)∗ | 51.085 | <0.001 |
| Baby/Infant (4 week–<1 year) | 18 (22.22%) | 58 (71.604%) | 81 (16.167%) | 21.053 | |
| Toddler (1– <3 years) | 8 (11.59%) | 58 (84.057%)∗ | 69 (13.77%) | 37.879 | |
| Preschooler (3– <5 years) | 11 (39.285%) | 17 (60.71%) | 28 (5.588%) | 1.2857 | |
| Childhood (5– <12 years) | 15 (23.809%) | 46 (73.015%) | 63 (12.57%) | 15 | |
| Adolescent (12–18 years) | 8 (17.77%) | 33 (73.33%) | 45 (8.98%) | 15.244 | |
|
| |||||
| Patient Type | |||||
| Indoor/Ward | 51 (19.615%) | 193 (74.23%)∗ | 260 (51.896%) | 82.639 | |
| Outdoor | 60 (24.89%) | 163 (67.634%) | 241 (48.104%) | 47.574 | |
|
| |||||
| Sample Types | |||||
| Urine | 49 (26.486%) | 125 (67.567%) | 185 (36.92%)∗ | 33.195 | <0.001 |
| Tracheal aspirates | 13 (13.54%) | 81 (84.375%)∗ | 96 (19.16%) | 49.191 | |
| Pus | 17 (28.33%) | 41 (68.33%) | 60 (11.976%) | 9.931 | |
| Blood | 9 (10.227%) | 70 (79.545%) | 88 (17.56%) | 47.101 | |
| Sputum | 10 (37.037%) | 11 (40.740%) | 27 (5.389%) | 0.047619 | |
| Wound swab | 6 (35.294%) | 17 (68%) | 25 (4.99%) | 5.2609 | |
| HVS | 7 (58.33%)∗ | 5 (41.6666%) | 12 (2.395%) | 0.33333 | |
| Throat swab | 0 (0.00%) | 5 (83.33%) | 6 (1.197%) | 5∗ | |
| Umbilical swab | 0 (0.00%) | 2 (100%) | 2 (0.399%) | 2∗ | |
|
| |||||
| Regional Distribution | |||||
| Urban | 137 | 178 | 315 | 0.69 | 0.4 |
| Rural | 73 | 113 | 186 | ||
∗ Correlation analysis between single drug and multidrug-resistance among different groups of Kpn isolates. ∗ indicates statistically significant (P value is less than 0.05).